There are about 141m renergen shares if the ASX website is...

There are about 141m renergen shares if the ASX website is accurate

US$55m (about R1bn) for 10% of Tetra4 to the CEF or maybe to the SOL Group that means the 90% of Tetra4 left with Renergen is valued at AUD781m.

So that would value the remaining 90% of Tetra4 to Renergen would be valued at 781/141 = AUD5.54/share

For the Nasdaq IPO Renergen were hoping for a maximum of about 67.5m shares to raise US150m. So about AUD3.52/share.

Then longterm Phase 2 ebitda projections are about AUD500m/yr. So the goal is to minimise dilution along the way currently at about 141m shares. If the Nasdaq IPO can be done with 67.5m shares that'll be about 210m shares at that stage. With further about US200m to be raised 1-2 years later hopefully at a higher shareprice being closer to Phase 2 production. ebitda of AUD500m/yr and 250m shares on issue would be fantastic down the line if it can be pulled off